- Home
- CTNM vs AMSF Comparison
CTNM vs AMSF Comparison
Compare CTNM & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CTNM | AMSF |
|---|---|---|
| Founded | 2009 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Accident &Health Insurance |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.7M | 519.4M |
| IPO Year | 2024 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CTNM | AMSF |
|---|---|---|
| Price | $17.05 | $26.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $19.00 | ★ $46.33 |
| AVG Volume (30 Days) | ★ 541.9K | 379.2K |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 8.61% |
| EPS Growth | ★ 0.46 | N/A |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $317,252,000.00 |
| Revenue This Year | N/A | $8.45 |
| Revenue Next Year | N/A | $6.03 |
| P/E Ratio | ★ N/A | $21.60 |
| Revenue Growth | N/A | ★ 2.66 |
| 52 Week Low | $8.60 | $25.65 |
| 52 Week High | $17.51 | $47.86 |
Technical Indicators
Market Signals| Indicator | CTNM | AMSF |
|---|---|---|
| Relative Strength Index (RSI) | 63.03 | 32.29 |
| Support Level | $13.65 | $25.65 |
| Resistance Level | N/A | $34.15 |
| Average True Range (ATR) | 0.98 | 0.65 |
| MACD | 0.18 | 0.07 |
| Stochastic Oscillator | 88.27 | 23.01 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.